Results of a high-resolution genome screen of 437 Alzheimer's disease families - PubMed (original) (raw)
. 2003 Jan 1;12(1):23-32.
doi: 10.1093/hmg/ddg007.
Lars Bertram, Aleister J Saunders, Thomas J Moscarillo, Marilyn S Albert, Howard Wiener, Rodney T Perry, Julianne S Collins, Lindy E Harrell, Rodney C P Go, Amy Mahoney, Terri Beaty, M Danielle Fallin, Dimitrios Avramopoulos, Gary A Chase, Marshal F Folstein, Melvin G McInnis, Susan S Bassett, Kimberly J Doheny, Elizabeth W Pugh, Rudolph E Tanzi; NIMH Genetics Initiative Alzheimer's Disease Study Group
Affiliations
- PMID: 12490529
- DOI: 10.1093/hmg/ddg007
Results of a high-resolution genome screen of 437 Alzheimer's disease families
Deborah Blacker et al. Hum Mol Genet. 2003.
Abstract
Alzheimer's disease (AD) is a devastating neurodegenerative disorder of late life with complex inheritance. Mutations in three known genes lead to the rare early-onset autosomal dominant form of AD, while a common polymorphism (epsilon 4) in the gene encoding apolipoprotein E (APOE ) is a risk factor for more typical late-onset (>60 years) AD. A recent study concluded that there are up to four additional genes with an equal or greater contribution to the disease. We performed a 9 cM genome screen of 437 families with AD, the full National Institute of Mental Health (NIMH) sample, which has been carefully ascertained, evaluated and followed by our group over the last decade. Performing standard parametric and non-parametric linkage analyses, we observed a 'highly significant' linkage peak by Lander and Kruglyak criteria on chromosome 19q13, which probably represents APOE. Twelve additional locations-on 1q23, 3p26, 4q32, 5p14, 6p21, 6q27, 9q22, 10q24, 11q25, 14q22, 15q26 and 21q22-met criteria for 'suggestive' linkage [i.e. two-point lod score (TLS) >/=1.9 and/or multipoint lod score (MLS) >/=2.2] in at least one of our analyses. Although some of these will surely prove to be false positives, these linkage signals should provide a valuable framework for future studies aimed at identifying additional susceptibility genes for late-onset AD.
Similar articles
- Candidate gene discovery procedure after follow-up confirmatory analyses of candidate regions of interests for Alzheimer's disease in the NIMH sibling dataset.
Baye TM, Perry RT, Wiener HW, Chen Z, Harrell LE, Go RC. Baye TM, et al. Dis Markers. 2008;24(6):293-309. doi: 10.1155/2008/736409. Dis Markers. 2008. PMID: 18688078 Free PMC article. - Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12.
Pericak-Vance MA, Bass MP, Yamaoka LH, Gaskell PC, Scott WK, Terwedow HA, Menold MM, Conneally PM, Small GW, Vance JM, Saunders AM, Roses AD, Haines JL. Pericak-Vance MA, et al. JAMA. 1997 Oct 15;278(15):1237-41. JAMA. 1997. PMID: 9333264 - Genetic studies on chromosome 12 in late-onset Alzheimer disease.
Wu WS, Holmans P, Wavrant-DeVrièze F, Shears S, Kehoe P, Crook R, Booth J, Williams N, Pérez-Tur J, Roehl K, Fenton I, Chartier-Harlin MC, Lovestone S, Williams J, Hutton M, Hardy J, Owen MJ, Goate A. Wu WS, et al. JAMA. 1998 Aug 19;280(7):619-22. doi: 10.1001/jama.280.7.619. JAMA. 1998. PMID: 9718053 - Dancing in the dark? The status of late-onset Alzheimer's disease genetics.
Bertram L, Tanzi RE. Bertram L, et al. J Mol Neurosci. 2001 Oct;17(2):127-36. doi: 10.1385/JMN:17:2:127. J Mol Neurosci. 2001. PMID: 11816786 Review. - Apolipoprotein E alleles as risk factors in Alzheimer's disease.
Roses AD. Roses AD. Annu Rev Med. 1996;47:387-400. doi: 10.1146/annurev.med.47.1.387. Annu Rev Med. 1996. PMID: 8712790 Review.
Cited by
- Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications.
Allen M, Zou F, Chai HS, Younkin CS, Miles R, Nair AA, Crook JE, Pankratz VS, Carrasquillo MM, Rowley CN, Nguyen T, Ma L, Malphrus KG, Bisceglio G, Ortolaza AI, Palusak R, Middha S, Maharjan S, Georgescu C, Schultz D, Rakhshan F, Kolbert CP, Jen J, Sando SB, Aasly JO, Barcikowska M, Uitti RJ, Wszolek ZK, Ross OA, Petersen RC, Graff-Radford NR, Dickson DW, Younkin SG, Ertekin-Taner N. Allen M, et al. Mol Neurodegener. 2012 Apr 11;7:13. doi: 10.1186/1750-1326-7-13. Mol Neurodegener. 2012. PMID: 22494505 Free PMC article. - A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer's disease.
Avramopoulos D, Wang R, Valle D, Fallin MD, Bassett SS. Avramopoulos D, et al. Neurogenetics. 2007 Apr;8(2):111-20. doi: 10.1007/s10048-007-0081-5. Epub 2007 Feb 16. Neurogenetics. 2007. PMID: 17334805 - Fine mapping of the chromosome 10q11-q21 linkage region in Alzheimer's disease cases and controls.
Fallin MD, Szymanski M, Wang R, Gherman A, Bassett SS, Avramopoulos D. Fallin MD, et al. Neurogenetics. 2010 Jul;11(3):335-48. doi: 10.1007/s10048-010-0234-9. Epub 2010 Feb 25. Neurogenetics. 2010. PMID: 20182759 Free PMC article. - Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease.
Lambert JC, Luedecking-Zimmer E, Merrot S, Hayes A, Thaker U, Desai P, Houzet A, Hermant X, Cottel D, Pritchard A, Iwatsubo T, Pasquier F, Frigard B, Conneally PM, Chartier-Harlin MC, DeKosky ST, Lendon C, Mann D, Kamboh MI, Amouyel P. Lambert JC, et al. J Med Genet. 2003 Jun;40(6):424-30. doi: 10.1136/jmg.40.6.424. J Med Genet. 2003. PMID: 12807963 Free PMC article. - Loss of Ataxin-1 Potentiates Alzheimer's Pathogenesis by Elevating Cerebral BACE1 Transcription.
Suh J, Romano DM, Nitschke L, Herrick SP, DiMarzio BA, Dzhala V, Bae JS, Oram MK, Zheng Y, Hooli B, Mullin K, Gennarino VA, Wasco W, Schmahmann JD, Albers MW, Zoghbi HY, Tanzi RE. Suh J, et al. Cell. 2019 Aug 22;178(5):1159-1175.e17. doi: 10.1016/j.cell.2019.07.043. Cell. 2019. PMID: 31442405 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous